The announcement follows $87m in series B funding which was secured earlier in 2024, dedicated to launching the ELITE-BTK trials. Credit: Shutterstock / GBJSTOCK US-based bioabsorbable scaffold ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

TCT 418: Efficacy and Safety of the Bioabsorbable Polymer Everolimus-Eluting Stent in Routine Clinical Practice: Data From the IRIS-DES Registry Receive the the latest news, research, and ...